SEOUL, April 4 (Korea Bizwire) — With patents on a wave of blockbuster drugs set to expire over the next five years, South Korea’s biopharmaceutical industry faces a critical window to capture a share of the rapidly expanding global contract development and manufacturing organization (CDMO) market, projected to be worth tens of trillions of won. [...]
SEOUL, March 17 (Korea Bizwire) — Major South Korean pharmaceutical and biotech companies are rapidly expanding their Contract Development and Manufacturing Organization (CDMO) facilities to meet growing global demand and strengthen their production capabilities for new business ventures. Samsung Biologics is preparing to complete its Plant 5 next month while simultaneously pushing forward with plans for Plant [...]
SEOUL, Feb. 26 (Korea Bizwire) — Acting President Choi Sang-mok on Wednesday reaffirmed the government’s commitment to turning South Korea into one of the world’s top five leaders in the advanced bio sector, stressing the emerging sector is comparable in size to major industries combined. “The global advanced bio industry was valued at US$2 trillion, [...]
SEOUL, Jan. 24 (Korea Bizwire) — The South Korean government has announced an ambitious initiative to position the country as one of the world’s top five biotech powerhouses by establishing a Korean-style bio cluster and accelerating AI- and data-driven biotech research and development (R&D). The plan aims to elevate the biotech industry to a level [...]
SEOUL, July 3 (Korea Bizwire) – Lotte Biologics Co. said Wednesday it has begun construction of its first production facility in South Korea, aiming to become one of the top 10 companies in the global contract development and manufacturing organization (CDMO) market. The plant, with a manufacturing capacity of 120,000 tons, is being built in [...]